Published in Infect Immun on April 01, 1994
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis. Clin Microbiol Rev (2009) 3.10
Transcriptional regulation of chemical diversity in Aspergillus fumigatus by LaeA. PLoS Pathog (2007) 2.44
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production. Eukaryot Cell (2006) 1.92
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med (1996) 1.87
Virulence factors of medically important fungi. Clin Microbiol Rev (1996) 1.83
Gliotoxin is a virulence factor of Aspergillus fumigatus: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone. Eukaryot Cell (2007) 1.69
Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium. Infect Immun (1995) 1.44
Transcriptional profiling identifies a role for BrlA in the response to nitrogen depletion and for StuA in the regulation of secondary metabolite clusters in Aspergillus fumigatus. Eukaryot Cell (2008) 1.41
Role of laeA in the Regulation of alb1, gliP, Conidial Morphology, and Virulence in Aspergillus fumigatus. Eukaryot Cell (2007) 1.41
A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe (2011) 1.41
The mitochondrial protein Bak is pivotal for gliotoxin-induced apoptosis and a critical host factor of Aspergillus fumigatus virulence in mice. J Cell Biol (2006) 1.28
Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites. Blood (2009) 1.28
Septic mice are susceptible to pulmonary aspergillosis. Am J Pathol (2003) 1.25
Frequency and species distribution of gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. J Clin Microbiol (2005) 1.17
Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol (2000) 1.12
Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol (2002) 1.09
In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Dig Dis Sci (2000) 0.95
The crucial role of the Aspergillus fumigatus siderophore system in interaction with alveolar macrophages. Microbes Infect (2010) 0.94
Loss of CclA, required for histone 3 lysine 4 methylation, decreases growth but increases secondary metabolite production in Aspergillus fumigatus. PeerJ (2013) 0.90
Correlation between the elastase activity index and invasiveness of clinical isolates of Aspergillus fumigatus. J Clin Microbiol (2002) 0.90
Tolerance has its limits: how the thymus copes with infection. Trends Immunol (2013) 0.88
Vibrio vulnificus induces macrophage apoptosis in vitro and in vivo. Infect Immun (2003) 0.86
Programmed cell death in thymus during experimental paracoccidioidomycosis. Med Microbiol Immunol (2003) 0.84
Complement Attack against Aspergillus and Corresponding Evasion Mechanisms. Interdiscip Perspect Infect Dis (2012) 0.83
Anti-Immune Strategies of Pathogenic Fungi. Front Cell Infect Microbiol (2016) 0.79
Gliotoxin Suppresses Macrophage Immune Function by Subverting Phosphatidylinositol 3,4,5-Trisphosphate Homeostasis. MBio (2016) 0.77
The Epipolythiodiketopiperazine Gene Cluster in Claviceps purpurea: Dysfunctional Cytochrome P450 Enzyme Prevents Formation of the Previously Unknown Clapurines. PLoS One (2016) 0.75
Gliotoxin potentiates osteoblast differentiation by inhibiting nuclear factor-κB signaling. Mol Med Rep (2015) 0.75
Anti-apoptotic effect of nerve growth factor is lost in congenital insensitivity to pain with anhidrosis (CIPA) B lymphocytes. J Clin Immunol (2004) 0.75
Apoptosis and programmed cell death in immunity. Annu Rev Immunol (1992) 4.47
Treatment of invasive aspergillosis with itraconazole. Am J Med (1989) 3.87
Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis (1992) 3.16
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A (1984) 1.74
The effect of gliotoxin upon macrophage function. Int J Immunopharmacol (1986) 1.50
DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem (1990) 1.23
Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol Immunol (1986) 1.17
Immunity to fungi. Curr Opin Immunol (1990) 1.14
Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis (1992) 1.12
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc (1991) 1.05
Clinical isolates of yeast produce a gliotoxin-like substance. Mycopathologia (1991) 1.02
Prevention of graft-versus-host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire. Transplantation (1988) 0.96
Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin. Proc Natl Acad Sci U S A (1987) 0.87
Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci U S A (1999) 1.86
Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc Natl Acad Sci U S A (1984) 1.74
Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods (1983) 1.68
Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol (1990) 1.67
Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem (1988) 1.63
Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol (1985) 1.61
In vitro- and ex vivo-derived cytolytic leukocytes from granzyme A x B double knockout mice are defective in granule-mediated apoptosis but not lysis of target cells. J Exp Med (1997) 1.61
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med (2001) 1.55
Granzyme A-deficient mice retain potent cell-mediated cytotoxicity. EMBO J (1995) 1.52
The effect of gliotoxin upon macrophage function. Int J Immunopharmacol (1986) 1.50
A T helper cell for anti-viral cytotoxic T-cell responses. J Exp Med (1979) 1.49
Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci U S A (1999) 1.46
Cell death induced by the Fas/Fas ligand pathway and its role in pathology. Immunol Cell Biol (1999) 1.41
The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology (1994) 1.27
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants. J Med Genet (2005) 1.25
An improved colorimetric assay for T cell cytotoxicity in vitro. J Immunol Methods (1984) 1.24
The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med Res Rev (1989) 1.20
Activated B cells can deliver help for the in vitro generation of antiviral cytotoxic T cells. Proc Natl Acad Sci U S A (1989) 1.19
Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol Immunol (1986) 1.17
Flavivirus infection up-regulates the expression of class I and class II major histocompatibility antigens on and enhances T cell recognition of astrocytes in vitro. J Neuroimmunol (1989) 1.16
Dihydropteridine reductase (DHPR), its cofactors, and its mode of action. Med Res Rev (1984) 1.15
Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7. Eur J Immunol (1992) 1.09
Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin. Cell Death Differ (2007) 1.08
Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection. J Virol (2001) 1.06
Functional analysis of macrophages, B cells and splenic dendritic cells as antigen-presenting cells in West Nile virus-specific murine T lymphocyte proliferation. Immunol Cell Biol (1991) 1.06
The generation and activation of memory class I MHC restricted cytotoxic T cell responses to influenza A virus in vivo do not require CD4+ T cells. Immunol Cell Biol (1989) 1.06
Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol (2001) 1.05
Apoptosis or programmed cell death. Med Res Rev (1991) 1.03
Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs. Cell Death Differ (2007) 1.03
A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes. Eur J Cell Biol (1995) 1.02
West Nile virus infection modulates the expression of class I and class II MHC antigens on astrocytes in vitro. Ann N Y Acad Sci (1988) 1.02
Preliminary analysis of murine cytotoxic T cell responses to the proteins of the flavivirus Kunjin using vaccinia virus expression. J Gen Virol (1991) 1.02
Identification of cytolytic lymphocytes in West Nile virus-infected murine central nervous system. J Gen Virol (1989) 1.01
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol (2000) 1.01
Cross-reactivity patterns of murine cytotoxic T lymphocytes. Cell Immunol (1979) 1.00
Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity. Immunol Rev (1996) 0.96
Neonatal tolerance to alloantigens alters major histocompatibility complex-restricted response patterns. Proc Natl Acad Sci U S A (1981) 0.96
Inactivation of rabbit muscle creatine kinase by reversible formation of an internal disulfide bond induced by the fungal toxin gliotoxin. J Biol Chem (2000) 0.96
Prevention of graft-versus-host disease by treatment of bone marrow with gliotoxin in fully allogeneic chimeras and their cytotoxic T cell repertoire. Transplantation (1988) 0.96
Non-H-2 and H-2-linked immune response genes control the cytotoxic T-cell response to H-Y. Immunogenetics (1982) 0.95
Gliotoxin causes oxidative damage to plasmid and cellular DNA. J Biol Chem (1988) 0.95
Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis. J Immunol (2000) 0.95
Different D end-dependent antigenic determinants are recognized by H-2-restricted cytotoxic T cells specific for influenza and Bebaru viruses. J Exp Med (1979) 0.94
Exacerbation of invasive aspergillosis by the immunosuppressive fungal metabolite, gliotoxin. Immunol Cell Biol (1996) 0.93
Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro. Immunol Cell Biol (1996) 0.93
IL-2-independent activity of IL-7 in the generation of secondary antigen-specific cytotoxic T cell responses in vitro. J Immunol (1993) 0.93
Restimulated memory Tc cells have a higher apparent avidity of interaction with targets than primary virus-immune Tc cells as indicated by anti-CD8 blocking. Immunol Cell Biol (1992) 0.92
Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res (2001) 0.92
Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis. Biosci Rep (1994) 0.92
Neonatal tolerance of major histocompatibility complex antigens alters Ir gene control of the cytotoxic T cell response to vaccinia virus. J Exp Med (1983) 0.90
Analysis of the cytotoxic T cell response to H-Y in CBA/H mice. J Immunol (1981) 0.90
Effector cytolotic function but not IFN-gamma production in cytotoxic T cells triggered by virus-infected target cells in vitro. Scand J Immunol (2001) 0.90
The immunomodulating agent gliotoxin causes genomic DNA fragmentation. Mol Immunol (1987) 0.90
Analysis of H-2 determinants recognized during the induction of H-Y-immune cytotoxic T cells by monoclonal antibodies in vitro. J Exp Med (1981) 0.89
Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses. J Gen Virol (1992) 0.89
Redox sensitive epidithiodioxopiperazines in biological mechanisms of toxicity. Redox Rep (2000) 0.88
The generation of memory antigen-specific cytotoxic T cell responses by CD28/CD80 interactions in the absence of antigen. Eur J Immunol (1997) 0.88
Enhancement of antigen-specific activation of CD8+ memory cytotoxic T cells by B cell-derived factors. Immunobiology (1992) 0.88
Hyperthermia and the generation and activity of murine influenza-immune cytotoxic T cells in vitro. J Virol (1984) 0.87
Cytotoxic T-cell response to H-Y in 'non-responder' CBA mice. Nature (1980) 0.87
Selection of the T-cell repertoire in transgenic mice expressing a transplantation antigen in distinct thymus subsets. Proc Biol Sci (1990) 0.87
Selective resistance of bone marrow-derived hemopoietic progenitor cells to gliotoxin. Proc Natl Acad Sci U S A (1987) 0.87
Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression. J Virol (1992) 0.87
Specific adsorption of H-2-restricted cytotoxi T cells to macrophage monolayers. J Exp Med (1978) 0.86
Virulence of mousepox virus is independent of serpin-mediated control of cellular cytotoxicity. Viral Immunol (2001) 0.85
Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum (1993) 0.85
Recognition of vaccinia virus-encoded major histocompatibility complex class I antigens by virus immune cytotoxic T cells is independent of the polymorphism of the peptide transporters. Proc Natl Acad Sci U S A (1993) 0.85
Extraaxial parasellar cavernous hemangioma. AJNR Am J Neuroradiol (1991) 0.85
Analysis of haplotype preference in the cytotoxic T-cell response to H-Y. Immunogenetics (1981) 0.84
Immunogenicity of two peptide determinants in the cytolytic T-cell response to flavivirus infection: inverse correlation between peptide affinity for MHC class I and T-cell precursor frequency. Viral Immunol (2001) 0.84
Actions of leukaemia inhibitory factor on megakaryocyte and platelet formation. Ciba Found Symp (1992) 0.83
Early onset periodontitis: a comparison and evaluation of two proposed modes of inheritance. Genet Epidemiol (1987) 0.83
Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice. Oncogene (2006) 0.83
Inhibition of human brain dihydropteridine reductase [E.C.1.6.99.10] by the oxidation products of catecholamines, the aminochromes. Biochem Biophys Res Commun (1983) 0.83
Lack of correlation between early intracellular calcium ion rises and the onset of apoptosis in thymocytes. Immunol Cell Biol (1994) 0.83
Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y. J Immunol (1981) 0.82
Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice. Cell Death Differ (2011) 0.82
Astrocytes are not susceptible to lysis by natural killer cells. J Neuroimmunol (1988) 0.82
Induction of T cell hyporesponsiveness to Bebaru in mice, and abnormalities in the immune responses of progeny of hyporesponsive males. Aust J Exp Biol Med Sci (1983) 0.81
Antiviral cytotoxic T cells cross-reactively recognize disparate peptide determinants from related viruses but ignore more similar self- and foreign determinants. J Immunol (2001) 0.81
Molecular basis of immune evasion strategies by adenoviruses. Immunol Cell Biol (1996) 0.81
Down-regulation of human adenovirus E1a by E3 gene products: evidence for translational control of E1a by E3 14.5K and/or E3 10.4K products. J Gen Virol (1994) 0.80
Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin. J Immunol (1999) 0.80
Adenovirus type 5 E3 gene products interfere with the expression of the cytolytic T cell immunodominant E1a antigen. Virology (1991) 0.80
Proteolytic processing of peptides in the lumen of the endoplasmic reticulum for antigen presentation by major histocompatibility class I. Eur J Immunol (2000) 0.79
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancers. Pathology (2012) 0.78
Specific epitope-induced conversion of CD8+ memory cells into effector cytotoxic T lymphocytes in vitro: presentation of peptide antigen by CD8+ T cells. Eur J Immunol (1992) 0.78
Antigen presentation in syrian hamster cells: substrate selectivity of TAP controlled by polymorphic residues in TAP1 and differential requirements for loading of H2 class I molecules. Immunogenetics (1999) 0.78
Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels. Biochem Pharmacol (1995) 0.78
Increased cell surface exposure of fucose residues is a late event in apoptosis. Biochem Biophys Res Commun (1998) 0.78
Quantitative considerations of T-cell activation and self tolerance. Immunol Rev (1987) 0.77
Classification of Barmah Forest virus as an alphavirus using cytotoxic T cell assays. J Gen Virol (1986) 0.77